← SynDRA
SALIRASIB
SynDRA canonical compound SYN0001409 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | MTOR | TRPA1 |
|---|
| Mechanism of action | mTOR inhibitor |
|---|
All known targets
- MTOR
- NRAS
- HRAS
- KRAS
- TRPA1
Mechanisms of action (all sources)
- HRAS INHIBITOR
- RAS inhibitor
- NRAS INHIBITOR
- KRAS INHIBITOR
- MTOR inhibitor
- NRAS ANTAGONIST
- MTOR MODULATOR
Drug classes
- Antineoplastic Agents
- Enzyme Inhibitors
Cross-references
Synonyms
- FTS
- Farnesylthiosalicylic acid
- S-Farnesylthiosalicylic acid
- UNII-MZH0OM550M
- MZH0OM550M
- CHEMBL23293
- AK186909
- Farnesyl Thiosalicylic Acid
- 2-[[(2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-yl]thio]benzoic Acid
- 2-[(2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienyl]sulfanylbenzoic acid
- 2-((2E,6E)-3,7,11-trimethyldodeca-2,6,10-trienylthio)benzoic acid
- 2-(((2E,6E)-3,7,11-Trimethyl-2,6,10-dodecatrienyl)sulfanyl)benzoic acid
- Benzoic acid, 2-(((2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl)thio)-
- Farnesylthiosalicyclic acid
- FTS, Thyreos
- Ras antagonists, Thyreos
- S-trans
- Th-101
- Trans-farnesylthiosalicylicacid
- FTS (oral, cancer), Concordia
- Farnesylthiosalicyclic acid (oral, cancer), Concordia
- Ras-inhibitors (cancer), Concordia
- FTS (oral, cancer), Concordia/Ono
- KD032
- salirasibum
- RefChem:884413
- DTXCID70910920
- MFCD00467723
- trans,trans-Farnesyl thiosalicylic acid
- Salirasib [USAN]
- Farnesylthiosalicylate
- Salirasib [USAN:INN]
- S-trans,trans-farnesylthiosalicylic acid
- Salirasib?
- Salirasib; FTS
- SALIRASIB [INN]
- Salirasib (INN/USAN)
- Lopac-F-8175
- SALIRASIB [WHO-DD]
Look up SALIRASIB in the interactive SynDRA portal →